By Shannon Firth; MedPage Today ~ May 03, 2017
WASHINGTON — From reciprocal approvals to rethinking coupon cards, health policy experts and economists offered targeted solutions to tackling drivers of increased drug spending at a briefing hosted by the Hutchins Center on Fiscal and Monetary Policy and the Center for Health Policy.
The reasons behind the growth in drug spending include everything from patient “kickbacks” to price-gouging and a lack of biosimilar competition, said policy experts at the meeting Tuesday at the Brookings Institution.
